Precedex 4 mcg (Dexmedetomidine (Dexmedetomidine Hydrochloride) SOLUTION) 4 MCG

Precedex 4 mcg is a sedative solution used for short-term sedation in intensive care units. This intravenous medication, containing dexmedetomidine hydrochloride, helps manage agitation and anxiety in hospitalized patients.

Strength

4 MCG

Pack Size

20ML/50ML/100ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Precedex 4 mcg is primarily used for sedation in critically ill patients who require mechanical ventilation. It is often administered to help manage agitation and anxiety in intensive care settings. This medication is designed to provide short-term sedation and is commonly used in hospitals for patients who need to be sedated but remain responsive.

Side Effects

Common effects of Precedex 4 mcg may include lowered heart rate and blood pressure. Patients might also experience drowsiness or dizziness. These effects are generally mild and temporary, but they can vary depending on the individual's response to the medication.

Precautions & Warnings

Precedex 4 mcg should be handled with care and administered by healthcare professionals. It is important to monitor patients closely for any adverse reactions. This medication should not be used in patients with known hypersensitivity to dexmedetomidine or any of its components.

Avoid Interactions

Precedex 4 mcg may interact with other sedatives, antihypertensives, and medications that affect the central nervous system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other depressants should be avoided while using this medication.

Frequently Asked Questions

Precedex 4 mcg is used for short-term sedation in intensive care units, particularly for patients who require mechanical ventilation and need to manage agitation and anxiety.

Precedex 4 mcg is administered intravenously by healthcare professionals in a controlled medical setting.

Common side effects may include lowered heart rate, blood pressure, drowsiness, and dizziness.

No, Precedex 4 mcg is intended for use in hospital settings under the supervision of healthcare professionals.

If you experience adverse reactions, inform your healthcare provider immediately for appropriate guidance and care.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.